Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Mueller, MC; Usadel, S; Kern, WV; Zirlik, A; Zhou, Q.
Proportion of patients eligible for statin therapy substantially varies between different cardiovascular disease risk calculators and guidelines used.
Int J STD AIDS. 2021; 32(13):1188-1195 Doi: 10.1177/09564624211029392
Web of Science PubMed FullText FullText_MUG


Co-Autor*innen der Med Uni Graz
Zirlik Andreas

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Because people living with HIV (PLWH) have an elevated risk for cardiovascular disease (CVD), prevention of CVD should be integrated in to HIV care. In this study, we compared the agreement between three risk scores and evaluated the indication for statin therapy based on guidelines of the American Heart Association and European AIDS Clinical Society. This study is a cross-sectional, single-center study. All PLWH ≥ 30 years without CVD and statin therapy were consecutively enrolled. Agreement between CVD risk estimates was assessed using Cohen's kappa coefficient. Of 488 PLWH, 41.2% were female with a median age of 47.8 years. D:A:D-R classified the highest proportion of patients in the categories of high/very high risk for CVD (17.8%) compared to SCORE (4.7%) and FRS (13.7%). D:A:D-R and SCORE (κ = 0.11) as well as D:A:D-R and FRS (κ = 0.33) showed poor agreement. Based on different CVD risk equations and guidelines, indication for statin therapy ranged from 34.8% to 92.0% of patients. In conclusion, a high proportion of PLWH is at high risk for CVD likely underestimated by treating physicians. Inconsistencies in the evaluation of CVD risk and primary prophylaxis should be tackled by an interdisciplinary approach.
Find related publications in this database (using NLM MeSH Indexing)
Cardiovascular Diseases - epidemiology, prevention & control
Cross-Sectional Studies - administration & dosage
Female - administration & dosage
Humans - administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Middle Aged - administration & dosage
Risk Assessment - administration & dosage
Risk Factors - administration & dosage
United States - administration & dosage

Find related publications in this database (Keywords)
Cardiovascular disease
European AIDS Clinical Society
American Heart Association
© Med Uni Graz Impressum